Translate
Telix Pharmaceuticals Ltd
About
Telix Pharmaceuticals Ltd (AU:TLX) — investor relations, events, news, and company updates on 6ix.
Latest News
Today
ProstACT Global Phase 3 (Part 1) Selected as Late-Breaking Abstract at ASCO 2026
Apr 15 2026
Telix Successfully Prices Upsized US$600M Convertible Bonds
Apr 14 2026
Telix Successfully Prices and Upsizes US$600 Million Convertible Bonds
Apr 14 2026
Telix Investor Presentation April 2026
Apr 14 2026
Telix Refinances Convertible Bonds
Financials
Revenue
A$803.79 M
Market Cap
A$4.49 B
EPS
-0.03